Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes

被引:37
作者
Fix, Anne [1 ]
Lucchesi, Carlo [1 ]
Ribeiro, Agnes [2 ]
Lequin, Delphine [1 ]
Pierron, Gaelle [2 ]
Schleiermacher, Gudrun [1 ,3 ]
Delattre, Olivier [1 ,2 ]
Janoueix-Lerosey, Isabelle [1 ]
机构
[1] Inst Curie, Lab Genet & Biol Cancers, INSERM, U830, F-75248 Paris 05, France
[2] Inst Curie, Unite Genet Somat, F-75248 Paris 05, France
[3] Inst Curie, Dept Pediat, F-75248 Paris 05, France
关键词
D O I
10.1002/gcc.20583
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Somatically acquired chromosomal imbalances are a key feature of neuroblastoma, a heterogeneous pediatric solid tumor Among these alterations, genomic amplification targeting the MYCN oncogene and observed in about 25-30% of the cases, strongly correlates with advanced stage and poor outcome. In this work, we have used BAC and SNP arrays as well as gene expression arrays to characterize amplifications in neuroblastoma. Eighty-eight distinct BACs defining high-level amplification events were identified in 65 samples, including 43 tumors and 22 cell lines. Although the highest recurrence was observed on chromosome 2, clones on chromosomes 8, 12, 16, and 17 also revealed genomic amplification in several samples. A detailed analysis of the 2p22-2p25 MYCN containing region indicated highly complex patterns in a number of cases. Coamplifications involving MYCN and other regions were explored by FISH in three cell lines. High-resolution arrays then allowed us to further refine the mapping of 25 amplicons in 19 samples, either reducing the size of a single continuous amplicon or increasing the complexity by highlighting multiple noncontiguous regions of amplification. Combined analysis of gene expression profiling and array-CGH data indicated that 12 to 25% of the genes that are targeted by genomic amplification are actually over-expressed in tumor cells, several of them having already been implicated in cancer. Finally, our results suggest that the presence of amplicons localized outside of chromosome 2, in addition to MYCN amplification, may be linked to a particularly severe outcome in neuroblastoma patients. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:819 / 834
页数:16
相关论文
共 45 条
[1]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[2]   Neuroblastoma: Biological insights into a clinical enigma [J].
Brodeur, GM .
NATURE REVIEWS CANCER, 2003, 3 (03) :203-216
[3]   High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays [J].
Carr, Jane ;
Bown, Nick P. ;
Case, Marian C. ;
Hall, Andrew G. ;
Lunec, John ;
Tweddle, Deborah A. .
CANCER GENETICS AND CYTOGENETICS, 2007, 172 (02) :127-138
[4]   CDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma -: art. no. 70 [J].
Chen, QR ;
Bilke, S ;
Wei, JS ;
Whiteford, CC ;
Cenacchi, N ;
Krasnoselsky, AL ;
Greer, BT ;
Son, CG ;
Westermann, F ;
Berthold, F ;
Schwab, M ;
Catchpoole, D ;
Khan, J .
BMC GENOMICS, 2004, 5 (1)
[5]   Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells:: the model of PIP gene duplication from a break at FRA7I [J].
Ciullo, M ;
Debily, MA ;
Rozier, L ;
Autiero, M ;
Billault, A ;
Mayau, V ;
El Marhomy, S ;
Guardiola, J ;
Bernheim, A ;
Coullin, P ;
Piatier-Tonneau, D ;
Debatisse, M .
HUMAN MOLECULAR GENETICS, 2002, 11 (23) :2887-2894
[6]   A COEFFICIENT OF AGREEMENT FOR NOMINAL SCALES [J].
COHEN, J .
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 1960, 20 (01) :37-46
[7]   MYCN IS RETAINED IN SINGLE-COPY AT CHROMOSOME-2 BAND-P23-24 DURING AMPLIFICATION IN HUMAN NEUROBLASTOMA-CELLS [J].
CORVI, R ;
AMLER, LC ;
SAVELYEVA, L ;
GEHRING, M ;
SCHWAB, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5523-5527
[8]   No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas [J].
De Preter, K ;
Speleman, F ;
Combaret, V ;
Lunec, J ;
Board, J ;
Pearson, A ;
De Paepe, A ;
Van Roy, N ;
Laureys, G ;
Vandesompele, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :3167-3168
[9]   High-resolution mapping of amplicons of the short arm of chromosome I in two neuroblastoma tumors by microarray-based comparative genomic hybridization [J].
Fix, A ;
Peter, M ;
Pierron, G ;
Aurias, A ;
Delattre, O ;
Janoueix-Lerosey, I .
GENES CHROMOSOMES & CANCER, 2004, 40 (03) :266-270
[10]   Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays [J].
George, Rani E. ;
Attiyeh, Edward F. ;
Li, Shuli ;
Moreau, Lisa A. ;
Neuberg, Donna ;
Li, Cheng ;
Fox, Edward A. ;
Meyerson, Matthew ;
Diller, Lisa ;
Fortina, Paolo ;
Look, A. Thomas ;
Maris, John M. .
PLOS ONE, 2007, 2 (02)